FDA Adverse Event Injury Summary report: N

3.5MM LCP® PROXIMAL HUMERUS PLATE-STANDARD 3H SHAFT/90MM

MDR report key: 3132296 · Received May 29, 2013

Report

Report Number
8030965-2013-02379
Event Type
Injury
Date Received
May 29, 2013
Date of Event
May 1, 2013
Report Date
April 30, 2013
Manufacturer
SYNTHES GMBH
Product Code
KTW
PMA / PMN Number
K011815
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS DEVICE IS USED FOR TREATMENT, NOT DIAGNOSIS. APPROXIMATE IMPLANT DATE REPORTED AS SIX OR SEVEN MONTHS PRIOR TO EXPLANT DATE (B)(6) 2012). INVESTIGATION IS ON GOING; NO CONCLUSION CAN BE DRAWN AS NO DEVICE WAS RETURNED. THE MANUFACTURING DOCUMENTS WERE REVIEWED AND NO COMPLAINT RELATED ISSUES WERE FOUND.

Description of Event or Problem · 1

APPROXIMATELY SIX TO SEVEN MONTHS AGO ((B)(6) 2012), PATIENT FELL AND REQUIRED AN ORIF PROCEDURE TO REPAIR THE RIGHT PROXIMAL HUMERUS. PATIENT WAS IMPLANTED WITH AN LCP PROXIMAL HUMERUS PLATE, 3.5MM LOCKING SCREWS AND 3.5MM CORTICAL SCREWS. PATIENT COMPLAINED OF POSTOPERATIVE PAIN AND SURGEON DIAGNOSED PATIENT WITH SYMPTOMATIC HARDWARE ISSUES. X-RAYS TAKEN ON (B)(6) 2013 CONFIRMED DIAGNOSIS OF HARDWARE ISSUES THAT HAD BEEN NOTED TWO WEEKS PRIOR. X-RAYS SHOWED THAT FOUR PROXIMAL LOCKING SCREWS HAD MIGRATED AND WERE PROTRUDING INTO THE JOINT. PATIENT UNDERWENT REVISION SURGERY ON (B)(6) 2013 TO REMOVE ALL HARDWARE. NO BROKEN HARDWARE NOTED. THERE WAS MINIMAL BLOOD LOSS DURING SURGERY, AND TOTAL SURGERY TIME WAS 15 MINUTES. THE PATIENT WAS EXAMINED BY FLUOROSCOPIC X-RAY POSTOPERATIVELY AND APPEARED HEALED. AS PER THE HOSPITAL, ALL REMOVED HARDWARE WILL BE RETAINED BY THE PATHOLOGY DEPARTMENT AND ARE NOT AVAILABLE FOR RETURN. THIS IS 1 OF 3 REPORTS FOR THE SAME EVENT, (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
236526 3.5MM LCP® PROXIMAL HUMERUS PLATE-STANDARD 3H SHAFT/90MM APPLIANCE, FIXATION,NAIL/BLADE/PLATE COMBO KTW SYNTHES GMBH 7901873

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention